Cancer cachexia

Michael S Yule^{1

2}, Leo R Brown³, Rachel Waller⁴, Stephen J Wigmore³

Affiliations

¹ St Columba's Hospice, Edinburgh EH5 3RW, UK michael.yule@ed.ac.uk.
² Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH4 2XU, UK.
³ Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
⁴ Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.

Michael S Yule et al. BMJ. 2024.

. 2024 Oct 23:387:e080040.

doi: 10.1136/bmj-2024-080040.

Michael S Yule^{1

2}, Leo R Brown³, Rachel Waller⁴, Stephen J Wigmore³

¹ St Columba's Hospice, Edinburgh EH5 3RW, UK michael.yule@ed.ac.uk.
² Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh EH4 2XU, UK.
³ Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
⁴ Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.

No abstract available

Conflict of interest statement

Competing interests: We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: none.